يعرض 1 - 12 نتائج من 12 نتيجة بحث عن '"reduced nicotinamide adenine dinucleotide phosphate oxidase/ec [Endogenous Compound]"', وقت الاستعلام: 0.40s تنقيح النتائج
  1. 1
    Electronic Resource

    مصطلحات الفهرس: randomized controlled trial, risk assessment, treatment duration, trough concentration, unspecified side effect/si [Side Effect], urinary excretion, urinary tract infection/dt [Drug Therapy], albumin/ec [Endogenous Compound], alfentanil/cb [Drug Combination], angiotensin receptor antagonist/dt [Drug Therapy], antibiotic agent/dt [Drug Therapy], astemizole/cb [Drug Combination], cisapride/cb [Drug Combination], clarithromycin/cb [Drug Combination], conivaptan/cb [Drug Combination], creatinine/ec [Endogenous Compound], cyclosporine/cb [Drug Combination], dihydroergotamine/cb [Drug Combination], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], ergotamine/cb [Drug Combination], fentanyl/cb [Drug Combination], indinavir plus ritonavir/cb [Drug Combination], itraconazole/cb [Drug Combination], ketoconazole/cb [Drug Combination], lopinavir plus ritonavir/cb [Drug Combination], pimozide/cb [Drug Combination], placebo, quinidine/cb [Drug Combination], rapamycin/cb [Drug Combination], reduced nicotinamide adenine dinucleotide phosphate oxidase/ec [Endogenous Compound], ritonavir/cb [Drug Combination], setanaxib/ae [Adverse Drug Reaction], setanaxib/ct [Clinical Trial], setanaxib/cb [Drug Combination], setanaxib/cm [Drug Comparison], setanaxib/cr [Drug Concentration], setanaxib/dt [Drug Therapy], setanaxib/pd [Pharmacology], tacrolimus/cb [Drug Combination], telaprevir/cb [Drug Combination], terfenadine/cb [Drug Combination], voriconazole/cb [Drug Combination], setanaxib/pk [Pharmacokinetics], clinical evaluation, clinical protocol, adult, aged, albuminuria/dt [Drug Therapy], animal experiment, antibiotic therapy, article, controlled study, creatinine blood level, creatinine urine level, diabetic nephropathy/dt [Drug Therapy], diabetic patient, double blind procedure, drug blood level, drug efficacy, drug safety, drug withdrawal, estimated glomerular filtration rate, female, human, insulin dependent diabetes mellitus/dt [Drug Therapy], major clinical study, male, microalbuminuria, mouse, multicenter study, nonhuman, outcome assessment, patient compliance, phase 2 clinical trial, physician, Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29385
    Contemporary Clinical Trials
    LibKey Link

  2. 2
  3. 3
  4. 4
    Electronic Resource
  5. 5
    Electronic Resource
  6. 6
    Electronic Resource
  7. 7
    Electronic Resource
  8. 8
    Electronic Resource

    المؤلفون: Sobey C.G., Drummond G.R.

    مصطلحات الفهرس: cerebrovascular accident, coronary artery disease, diabetes mellitus/et [Etiology], electron transport, endoplasmic reticulum, endothelial dysfunction, endothelium, endothelium cell, enzyme activity, gene deletion, gene overexpression, glucose blood level, human, hypercholesterolemia, hyperglycemia/et [Etiology], hyperlipidemia/et [Etiology], hypertension/et [Etiology], inflammation, insulin resistance/et [Etiology], macrophage, metabolic syndrome X, nonhuman, obesity, oxidative stress, priority journal, renin angiotensin aldosterone system, review, smooth muscle fiber, umbilical vein endothelial cell, vascular disease/et [Etiology], vascular smooth muscle, vasodilatation, advanced glycation end product/ec [Endogenous Compound], angiotensin II/ec [Endogenous Compound], apocynin, endothelial nitric oxide synthase/ec [Endogenous Compound], glucose/ec [Endogenous Compound], nitric oxide/ec [Endogenous Compound], reduced nicotinamide adenine dinucleotide phosphate oxidase 4/ec [Endogenous Compound], superoxide/ec [Endogenous Compound], unclassified drug, vascular cell adhesion molecule 1/ec [Endogenous Compound], reduced nicotinamide adenine dinucleotide phosphate oxidase 5/ec [Endogenous Compound], oxidized low density lipoprotein/ec [Endogenous Compound], peroxynitrite, reactive oxygen metabolite/ec [Endogenous Compound], reduced nicotinamide adenine dinucleotide phosphate oxidase/ec [Endogenous Compound], reduced nicotinamide adenine dinucleotide phosphate oxidase 1/ec [Endogenous Compound], reduced nicotinamide adenine dinucleotide phosphate oxidase 2/ec [Endogenous Compound], apoptosis, atherosclerosis, bioavailability, blood clotting, blood vessel wall, cardiovascular risk, cell death, cell membrane, cell nucleus membrane, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41764
    Trends in Endocrinology and Metabolism
    Click here for full text options
    LibKey Link

  9. 9
    Electronic Resource
  10. 10
    Electronic Resource

    المؤلفون: Tesch G.H., Nikolic-Paterson D.J.

    مصطلحات الفهرس: genetic susceptibility, glomerulosclerosis/co [Complication], glomerulosclerosis/et [Etiology], inbred strain, inflammation, insulin deficiency, insulin dependent diabetes mellitus, insulin resistance, kidney fibrosis/co [Complication], kidney fibrosis/et [Etiology], kidney injury, knockout mouse, macrophage, male, mouse, non insulin dependent diabetes mellitus, nonhuman, oxidative stress, priority journal, renal protection, short survey, streptozocin diabetes, transgenic mouse, advanced glycation end product/ec [Endogenous Compound], antioxidant/ec [Endogenous Compound], apocynin/dt [Drug Therapy], apocynin/pd [Pharmacology], catalase/ec [Endogenous Compound], cytokine/ec [Endogenous Compound], glutathione peroxidase/ec [Endogenous Compound], hydrogen peroxide/ec [Endogenous Compound], imatinib/dt [Drug Therapy], imatinib/pd [Pharmacology], plasminogen activator inhibitor 1/ec [Endogenous Compound], platelet derived growth factor/ec [Endogenous Compound], platelet derived growth factor receptor/ec [Endogenous Compound], reactive oxygen metabolite/ec [Endogenous Compound], reduced nicotinamide adenine dinucleotide phosphate oxidase/ec [Endogenous Compound], Smad2 protein/ec [Endogenous Compound], Smad3 protein/ec [Endogenous Compound], streptozocin, superoxide dismutase/ec [Endogenous Compound], thioredoxin/ec [Endogenous Compound], transforming growth factor beta/ec [Endogenous Compound], female, interleukin 1/ec [Endogenous Compound], mitogen activated protein kinase p38/ec [Endogenous Compound], monocyte chemotactic protein 1/ec [Endogenous Compound], osteonectin/ec [Endogenous Compound], peroxiredoxin/ec [Endogenous Compound], peroxynitrite/ec [Endogenous Compound], animal experiment, animal model, controlled study, diabetic nephropathy/co [Complication], diabetic nephropathy/dt [Drug Therapy], diabetic nephropathy/et [Etiology], experimental mouse, gene mutation, Short Survey

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32178
    Click here for full text options
    LibKey Link

  11. 11
    Electronic Resource

    المؤلفون: Tesch G.H., Nikolic-Paterson D.J.

    مصطلحات الفهرس: genetic susceptibility, glomerulosclerosis/co [Complication], glomerulosclerosis/et [Etiology], inbred strain, inflammation, insulin deficiency, insulin dependent diabetes mellitus, insulin resistance, kidney fibrosis/co [Complication], kidney fibrosis/et [Etiology], kidney injury, knockout mouse, macrophage, male, mouse, non insulin dependent diabetes mellitus, nonhuman, oxidative stress, priority journal, renal protection, short survey, streptozocin diabetes, transgenic mouse, advanced glycation end product/ec [Endogenous Compound], antioxidant/ec [Endogenous Compound], apocynin/dt [Drug Therapy], apocynin/pd [Pharmacology], catalase/ec [Endogenous Compound], cytokine/ec [Endogenous Compound], glutathione peroxidase/ec [Endogenous Compound], hydrogen peroxide/ec [Endogenous Compound], imatinib/dt [Drug Therapy], imatinib/pd [Pharmacology], plasminogen activator inhibitor 1/ec [Endogenous Compound], platelet derived growth factor/ec [Endogenous Compound], platelet derived growth factor receptor/ec [Endogenous Compound], reactive oxygen metabolite/ec [Endogenous Compound], reduced nicotinamide adenine dinucleotide phosphate oxidase/ec [Endogenous Compound], Smad2 protein/ec [Endogenous Compound], Smad3 protein/ec [Endogenous Compound], streptozocin, superoxide dismutase/ec [Endogenous Compound], thioredoxin/ec [Endogenous Compound], transforming growth factor beta/ec [Endogenous Compound], female, interleukin 1/ec [Endogenous Compound], mitogen activated protein kinase p38/ec [Endogenous Compound], monocyte chemotactic protein 1/ec [Endogenous Compound], osteonectin/ec [Endogenous Compound], peroxiredoxin/ec [Endogenous Compound], peroxynitrite/ec [Endogenous Compound], animal experiment, animal model, controlled study, diabetic nephropathy/co [Complication], diabetic nephropathy/dt [Drug Therapy], diabetic nephropathy/et [Etiology], experimental mouse, gene mutation, Short Survey

  12. 12
    Electronic Resource